Windar Photonics PLC (AIM: WPHO) — Investment Research Note

Executive summary

Windar Photonics is a Danish-based, UK-listed micro-cap that sells LiDAR wind sensors and Nexus optimisation software to wind-turbine operators, historically delivering low single-digit AEP uplifts for retrofit V82 fleets. Across the filings the operating trajectory has been three years of chronic delivery slippage and dependence on a handful of large Chinese/North American orders, culminating in the discovery of ~€2.8m of potentially fraudulent revenue in FY24/FY25, a collapse in FY26 revenue guidance from €7.8m to €1.8m, and the temporary suspension of the shares from AIM on 17 June 2026 2026-06-17 suspension; 2026-06-23 trading update. The single most important valuation point today is that the business is functionally out of cash (€85k at 31 May 2026, versus €4m six months earlier), reliant on the £20m GEM equity-drawdown facility priced at 90% of a market that is currently suspended, and facing a forensic accounting investigation before the FY25 audit can even complete — the €26m listed market cap does not reflect the certain dilution and going-concern risk ahead.

Fair value estimate

Range: 3 – 12 pence per share, implying a market cap of £3m – £12m.
Methodology: distressed sum-of-parts / recoverable-value framework. There is no meaningful EBITDA to multiply and no visibility on FY27+ revenue that would support a DCF. I anchor on (a) the €3.7m of finished-goods inventory less obligations, (b) a modest option value on the technology and installed base (~25% of NA V82 fleet), and (c) an assumed heavily dilutive re-cap (£4–6m raised at a 50-70% discount to a re-opened price) required to restore going concern. On a "surviving but massively diluted" outcome the recoverable equity is well below the current £26m mark.
Comparison to £26.0m disclosed cap: implied downside of ~55% to ~90% versus the last-traded 27p. Note the price feed shows £0.27 both pre- and post-suspension; the shares have not traded meaningfully since 17 June 2026 and the "current" cap does not price in the accounting scandal or funding gap.
Absolute downside: c. -55% to -89%.

Sector context

Sector confirmed: Industrial Goods and Services / renewable-energy capital equipment. Not a natural AI-beneficiary sector.
Quality/growth/leverage profile is well below typical peers — sub-scale (FY25 revenue ~€6m, since impaired), loss-making, single-product hardware business now with confirmed control failures.
Listed peers: Windtech-adjacent names include Vaisala (VAIALV, Finnish sensor group), Zephir Ltd (private, UK LiDAR), Leosphere / Vaisala Xstream, and larger turbine OEMs Vestas (VWS DC) and Siemens Gamesa (integrated inside Siemens Energy ENR GY). Windar is orders-of-magnitude smaller than any listed comparator.

Investment thesis (3 bullets)

Genuine niche technology with proven ROI on V82 fleets — the WindEye + WindTimizer + Nexus stack has demonstrated 2-4% AEP uplift and is installed on ~25% of North American V82 turbines, providing a real reference base for eventual recovery 2025-12-23 trading statement; 2025-09-15 interim.
Optionality on a scrubbed re-listing at a low base — if the forensic review is contained and the GEM £20m facility (or an alternative placing) succeeds, the equity has meaningful upside from a distressed re-basing given €3.7m of usable inventory and an active test-order pipeline across nine IPPs globally 2026-06-23 trading update; 2026-04-15 trading update.
New CEO Andreas Berg Nielsen brings genuine sector credibility — nearly two decades at Siemens Gamesa and KK Wind Solutions, engaged from 1 June 2026 with a three-step operational plan expected alongside the delayed FY25 report 2026-06-23 trading update; 2025-07-01 final results.

Key risks (3 bullets)

Accounting irregularities are confirmed and material — €2.8m of aggregate FY24/FY25 revenue is under investigation, sourced from two Chinese customers whose bona fide status is in doubt; the FY25 audit cannot complete before forensic work is done, and the shares are in breach of AIM Rule 19 2026-06-17 potential accounting irregularities.
Acute liquidity crisis — gross cash of €85k at 31 May 2026 versus €4.0m at 31 December 2025; the board itself flagged "significant working capital constraints before the end of July" and needs equity or a cash injection inside that window 2026-06-17. The GEM facility prices at 90% of a suspended stock and is undrawable in current form.
Order-book air-pocket — two FY26 orders worth €6m are "on hold" with "fair possibility [they] will not be awarded", collapsing FY26 revenue guidance from €7.8m to €1.8m (a ~77% cut) 2026-06-23. Historic pattern of orders slipping (e.g., 2025 China order slip, 2023 supply-chain misses, 2024 €1.25m order recognised only in 2025) is a structural feature of the customer base, not a one-off.

Operating leverage

On paper the model has substantial operating leverage — H1 2025 delivered a 62% gross margin trajectory with fixed staff costs of ~€2.0m and a manufacturing facility sized for a 5x production step-up ("quintupling capacity") that has now been built and paid for 2025-09-15 interim; 2025-08-01 AGM statement. FY24 admin expenses of €3.4m were largely fixed, meaning that at the previously-guided €7.8m FY26 revenue the business would have flipped to modest EBITDA positive; on the revised €1.8m guidance the leverage works catastrophically in reverse — gross profit collapses to roughly €0.9m against ~€3.5m+ of fixed costs. The leverage is real and structural (specialised sensor manufacturing with fixed R&D and central overhead) but only monetisable if revenue can be restored to the €6-10m range, and even then contribution margins on incremental hardware are meaningfully below software margins (which remain nascent). Right now the operating leverage is a liability, not an asset.

Value-trap signals

Repeated guidance misses across FY23, FY24, FY25 and FY26.
Confirmed accounting irregularities relating to revenue recognition.
Auditor rotation (Gravita) mid-crisis and delayed audit.
Extreme customer concentration (three customers = 88% of FY24 revenue).
Two-year window of "record" orders that repeatedly slip into the next period.
CEO change during crisis (1 June 2026).
€0.4m commitment fee paid to GEM in Fee Shares before the facility could be drawn.
Historic reliance on rolling equity placings to fund losses (April 2024, December 2024, planned 2026).
Suspension from AIM in breach of Rule 19.
Directors' fees historically settled in shares.

Earnings vs. expectations

Across the filings the pattern is one of consistent misses versus both consensus and prior guidance. FY23 revenue of €4.8m came in modestly below the pre-year run-rate implied by mid-year commentary; FY24 landed at €4.6m against ~€5.7m indicated in the March 2025 pre-close (a €1.4m order was pushed into FY25); FY25 revenue of €6.4m was "short of expectations" against consensus of €9.45m revenue / €2.2m EBITDA (the company itself flagged the gap explicitly) 2025-12-23; and FY26 has now been reset from €7.8m to €1.8m — a 77% guidance cut inside two months. The pattern is emphatic under-delivery, and part of the shortfall is now believed to have been made up by potentially fictitious revenue. This is a "repeated profit warnings" track record.

Conviction

Conviction: 4 (high) — that the stock is overvalued at the current £26m cap.

Anchors: (i) €85k of cash against imminent funding need is a documented, near-certain dilution catalyst; (ii) confirmed €2.8m accounting irregularity with forensic review pending removes the ability to rely on any historical numbers as a valuation anchor; (iii) FY26 revenue collapse is directly disclosed by the company.
Limits: (i) the technology and installed base have genuine option value that is hard to quantify precisely — a well-structured re-cap plus commercial recovery could deliver meaningful upside from a much lower base; (ii) the shares have not traded since 17 June 2026, so the £26m cap is a stale reference point rather than a live market clearing price.